Pharmacokinetics, Pharmacodynamics Profile and Tolerance of HRS-9231 in Healthy Subjects
Clinical trial NCT07123376 · COMPLETED
Trial details
- NCT number
- NCT07123376
- Sponsor
- Shanghai Shengdi Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-05
- Primary completion
- 2024-10-06
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.